International Conference used FDA-approved tools to see how sleep can impact other parts of recovery for patients in the ...

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

Panelists discuss how early diagnosis of immunoglobulin A (IgA) nephropathy enables timely interventions that can ...

Panelists discuss how disease-modifying therapies for immunoglobulin A (IgA) nephropathy, though initially more expensive ...

Panelists discuss how currently available ALK inhibitors compare in terms of efficacy, durability of response, and central ...

M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient chronic obstructive ...

The latest results from the phase 3 FIBRONEER-IPF trial showed consistent benefit of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF) whether or not they were receiving background ...

Margrit Wiesendanger, MD, PhD, explores lupus symptoms, diagnosis challenges, and the importance of early detection to prevent inflammation-related damage.

Solutions depend on listening to individuals with lived experience, rebuilding trust, and recognizing the humanity of every ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...